Creo Medical Group is a medical device company based in Wales that develops instruments for minimally invasive surgery and endoscopy. Its technology combines radiofrequency energy for cutting and coagulation with microwave energy for ablation, and it supplies devices such as the Speedboat and MicroBlate instruments to hospitals and clinicians. The company also provides related training and support services to healthcare providers, helping physicians use its equipment in gastrointestinal and soft tissue procedures.
Creo Medical Group PLC trades under the code CREO on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2873 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
21/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-13.8%
From 52-week high-36.6%
MomentumWeak
36/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-18.2%
6-month return-7.2%
12-month, skipping last month10.1%
Stability (higher is calmer)Weak
25/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)52.2%
Worst drawdown, 1 year (smaller is calmer)-45.6%
LiquidityStrong
72/100
Trades actively.
See the numbers →
Avg daily value traded8.43M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 9.50 – 18.50Daily closes, split-adjusted
Signals
50-day average11.77
200-day average13.05
Golden/death cross (60d)Death, 24 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.54
Technical summary
Daily
Bearish
5 bullish · 3 neutral · 8 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 2 neutral · 6 bearish
Moving averages (daily)
SMA 10
10.88
Bullish
EMA 10
10.98
Bullish
SMA 20
10.56
Bullish
EMA 20
11.00
Bullish
SMA 50
11.77
Bearish
EMA 50
11.58
Bearish
SMA 100
12.70
Bearish
EMA 100
12.16
Bearish
SMA 200
13.05
Bearish
EMA 200
12.64
Bearish
Oscillators (daily)
RSI (14)
53.73
Neutral
MACD (12, 26)
-0.15
Bearish
Momentum (12)
7.14
Bullish
Stochastic %K (14)
66.67
Neutral
Williams %R (14)
-33.33
Neutral
CCI (20)
135.8
Bearish
Pivot points (classic, last session)
S3
10.50
S2
10.75
S1
11.00
Pivot
11.25
R1
11.50
R2
11.75
R3
12.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
